Back to Hematology
Hematologyv2008Evidence-Based

Khorana Score (Chemotherapy-Associated VTE Risk)

Predicts risk of venous thromboembolism in ambulatory cancer patients starting chemotherapy.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
khorana
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Khorana Score (Chemotherapy-Associated VTE Risk) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within hematology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Sum: cancer site (0-2) + platelets>=350 (1) + Hb<10 or ESA (1) + WBC>11 (1) + BMI>=35 (1). Range 0-6.

Clinical Pearls & Practice Notes

  • Validated in ambulatory patients initiating chemotherapy. Do not apply to hospitalized or post-surgical patients.

Evidence & Literature Citations

  1. Khorana AA, Kuderer NM, Culakova E, et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111(10):4902-4907.

Score Interpretation Ranges

Low risk0 – 0 pts

Score 0

Intermediate risk1 – 2 pts

Score 1-2

High risk3 – pts

Score 3+

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.